Description
The Action will provide a cooperative framework to support the research on beneficial biological effects of non-ionizing electromagnetic fields (EMFs) and their use in biomedical applications. Research on biological effects of EMFs has traditionally focused on health risks. Inspired by promising recent studies on useful biomedical EMF interactions and applications, this Action will focus on beneficial effects, aiming for breakthrough results, new discoveries and innovative biomedical technologies. The Action will provide a better understanding of underlying physical and biological interaction mechanisms, related to both cancer and non-cancer applications, filling the gaps in the present state of knowledge. Ultimately, the Action will aim to contribute to development and optimization of innovative EMF-based medical devices and procedures, which will be safer, more efficient and less invasive. Interdisciplinarity of the proposed topic and significance of the expected outcomes require a concerted research network at the European level.
Action keywords
beneficial effects of EMFs - biomedical applications of EMFs - cancer and non-cancer interactions - EMF stimulation of cells and tissues - measurements and in silico tools for EMF dosimetry
Parties
Action Leadership Positions
Role | Leader |
---|---|
Action Chair | |
Action Vice-Chair | |
Grant Holder Scientific Representative | |
STSM Coordinator | |
WG1 Leader | |
WG2 Leader | |
WG3 Leader |
Management Committee
Country | MC Member |
---|---|
Austria | |
Austria | |
Belgium | |
Belgium | |
Bosnia and Herzegovina | |
Bosnia and Herzegovina | |
Bulgaria | |
Bulgaria | |
Croatia | |
Cyprus | |
Czech Republic | |
Czech Republic | |
Czech Republic | |
Denmark | |
Estonia | |
Estonia | |
Finland | |
France | |
France | |
Germany | |
Germany | |
Greece | |
Greece | |
Hungary | |
Hungary | |
Ireland | |
Ireland | |
Israel | |
Israel | |
Italy | |
Italy | |
Lithuania | |
Malta | |
Malta | |
Netherlands | |
Netherlands | |
North Macedonia | |
North Macedonia | |
Norway | |
Poland | |
Poland | |
Portugal | |
Portugal | |
Romania | |
Romania | |
Serbia | |
Serbia | |
Slovakia | |
Slovakia | |
Slovenia | |
Slovenia | |
Spain | |
Spain | |
Sweden | |
Switzerland | |
Switzerland | |
Türkiye | |
Türkiye | |
United Kingdom | |
United Kingdom |
Country | MC Substitute |
---|---|
Austria | |
Austria | |
Belgium | |
Belgium | |
Croatia | |
Croatia | |
Czech Republic | |
Czech Republic | |
Czech Republic | |
Estonia | |
Finland | |
Finland | |
France | |
Germany | |
Greece | |
Italy | |
Italy | |
Italy | |
Malta | |
Netherlands | |
Netherlands | |
Norway | |
Poland | |
Poland | |
Portugal | |
Portugal | |
Romania | |
Serbia | |
Serbia | |
Slovakia | |
Slovakia | |
Slovakia | |
Slovenia | |
Spain | |
Spain | |
Spain | |
Switzerland | |
United Kingdom | |
United Kingdom |
COST Near Neighbour Countries
Institution Name | MC Observer |
---|---|
University of Shkodra ‘Luigj Gurakuqi’ |
COST International Partner Countries
Institution Name | MC Observer |
---|---|
GE Global Research |